Home / HealthNews / Johnson & Johnson fined 25 million euros by French competition watchdog

Johnson & Johnson fined 25 million euros by French competition watchdog

PARIS (Reuters) – France’s competition authority said on Wednesday it had fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.62 million) relating to a case involving the pain killer product durogesic.

Durogesic is sold as a skin patch to control on-going moderate to severe pain. Because it contains opioid fentanyl, misusage can lead to death by overdose.

Officials at Johnson & Johnson could not be immediately reached for comment.

Reporting by Matthias Blamont; Writing by Sudip Kar-Gupta; Editing by Dominique Vidalon

About admin

Check Also

FDA plans more restrictive policy for bulk drug compounding

(Reuters) – The head of the U.S. Food and Drug Administration on Thursday said it …

Leave a Reply

Your email address will not be published. Required fields are marked *